Asia Pacific bioabsorbable stents market is advancing to achieve USD 873.1 million by 2023 from USD 128.2million by 2018, growing at a CAGR of 46.5% in the course of forecast period. Stents are by and large used as a part of the treatment of blocked arteries. Stents are little and expandable work tubes that hold routes open and help treat peripheral and coronary artery diseases. Bioabsorbable stents are portrayed as totally biodegradable stents that thoroughly vanishes over time.
A stent is a metallic or a polymer tube implanted into the lumen of any vein or a duct in order to keep the passage open. Various stents for different clinical conditions are available in the market. A stent insert is most ordinarily used for the treatment of heart variations from the normal, for instance blocked veins. Stents are implanted in the throat to allow the passage of sustenance and beverages in patients experiencing esophageal growth. They can likewise be utilized as a part of kidneys, abdomen and gastrointestinal tract for different purposes. Utilizing of bioabsorbable stents rather than permanent metallic stents eliminates the need to experience second surgery to remove the metallic stents.
Augment in cardiovascular surgeries is because of ascend in risk of cardiovascular issue among the general population experiencing Obesity. According to WHO reports, cardio vascular issues are the primary source of death than whatever other medical problems, it is normal that by 2030 more than 23 million people face death because of Cardio vascular diseases. Thus, aging population and increment in the cardiovascular illnesses are the key driving elements for the development of the Asia Pacific bioabsorbable stents. Positive results of surgeries with bioabsorbable stents and Post-surgery reports likewise represents the improvement of market. However, there are numerous administrative, mechanical, safety-viability and furthermore cost related issues which should be managed before achieving its maximum capacity.
The Asia Pacific bioabsorbable stents market is segmented into different categories based on material, absorption rate, application and end user. Based on material, bioabsorbable stents can be divided into two types. They are polymer stents, and metallic stents. Polymer stents are expected to grow at a higher CGAR compared to metallic stents. Based on absorption rate, Asia Pacific bioabsorbable stents is segmented into slow absorption rate stents and high absorption rate stents. In 2018, market for slow absorption stents is predicted to be on higher side. By application, bioabsorbable stents are categorized as coronary artery disease and peripheral artery disease. Coronary artery disease is expected to have larger share than peripheral artery disease. On the basis of end user, market can be segmented into hospitals and cardiac centers. The market is dominated by hospitals. On the basis of geography, the highest market share holder is Europe, followed by North America.
Few major players in Asia Pacific bioabsorbable stents are Arterial Remodeling Technologies S.A, Biotronik, Abbott Laboratories, Xenogenics Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Amaranth Medical, Reva Medical, Inc. Tepha, Inc, SMT, Arterius Limited.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Material
5.1.1 Introduction
5.1.2 Polymer stents
5.1.3 Metallic stents
5.1.4 Y-o-Y Growth Analysis, By Material
5.1.5 Market Attractiveness Analysis, By Material
5.1.6 Market Share Analysis, By Material
5.2 Absorption
5.2.1 Introduction
5.2.2 Slow absorbtion stents
5.2.3 High absorbtion stents
5.2.4 Y-o-Y Growth Analysis, By absorption
5.2.5 Market Attractiveness Analysis, By absorption
5.2.6 Market Share Analysis, By absorption
5.3 Application
5.3.1 Introduction
5.3.2 coronary artery disease
5.3.3 peripheral artery disease
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Cardiac centers
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Material
6.1.3.3 By absorption
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Material
6.1.4.3 By absorption
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Material
6.1.5.3 By Absorbtion
6.1.5.4 By Application
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Elixir Medical Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Arterius Limited
8.3 Amaranth Medical Inc
8.4 Abbott Laboratories
8.5 Arterial Remodeling Technologies S.A
8.6 Biotronik
8.7 Kyoto Medical Planning Co Ltd
8.8 Reva Medical Inc
8.9 Tepha.Inc
8.10 Xenogenics Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
